Company Redwood Pharma AB

Equities

REDW

SE0021512134

Pharmaceuticals

Delayed Nasdaq Stockholm 09:07:36 2024-05-27 EDT 5-day change 1st Jan Change
0.968 SEK +19.21% Intraday chart for Redwood Pharma AB -6.92% -79.40%

Business Summary

Redwood Pharma AB is a Sweden-based company, which is primarily focused on pharmaceutical industry. The Company develops IntelliGel, a patented hydrogel drug delivery platform technology. IntelliGel is a patented supramolecular smart drug delivery system with an ability to dissolve water-insoluble and sparingly soluble drugs, or disperse, suspend and stabilize otherwise insoluble drugs. It is an odor-free, clear and transparent hydrogel with low solid content, and forms an invisible patch when applied to a surface. The Company’s development product is focused on treatment of chronic Dry Eye Disease (DED) in post-menopausal women. It is based on a naturally occurring, endogenous molecule found in the body.

Number of employees: 1

Managers

Managers TitleAgeSince
Founder 58 12-01-19
Founder 63 12-01-19
Chairman 68 15-12-31
Director of Finance/CFO 68 16-03-20

Members of the board

Members of the board TitleAgeSince
Founder 63 12-01-19
Director/Board Member 51 23-05-31
Founder 58 12-01-19
Chairman 68 15-12-31
Director/Board Member - 22-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 21,231,000 20,971,105 ( 98.78 %) 0 98.78 %

Company contact information

Redwood Pharma AB

Ringvägen 100E 9th Floor

118 60, Stockholm

+

http://www.redwoodpharma.com
address Redwood Pharma AB(REDW)
  1. Stock Market
  2. Equities
  3. REDW Stock
  4. Company Redwood Pharma AB